Morgan Stanley Knock-Out ADN1/D/ DE000ME2E4C3 /
2024-05-28 10:50:04 AM | Chg.0.00 | Bid2:37:46 PM | Ask2:37:46 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.29EUR | 0.00% | 2.19 Bid Size: 3,750 |
2.29 Ask Size: 3,750 |
ADESSO SE INH O.N. | 76.5549 EUR | 2078-12-31 | Call |
GlobeNewswire
2:53 PM
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. In...
GlobeNewswire
2:45 PM
Wearable Devices XR Team's Report: The Mudra’s Neural Technology to Power Future XR Devices
GlobeNewswire
2:45 PM
Aprea Therapeutics Announces that Safety Review Committee (SRC) Endorses Dosing of Patients with ATR...
GlobeNewswire
2:40 PM
AITX’s RAD Announces First Paid Analytic based on Vast Improvements in Its Firearm Detection Speed &...
GlobeNewswire
2:39 PM
Specialized Education Services, Inc. Unveils 2024 Staff and Teacher of the Year Winners
GlobeNewswire
2:31 PM
Mama’s Creations to Host First Quarter and Fiscal Year 2025 Earnings Call on June 11 at 4:30 p.m. Ea...
GlobeNewswire
2:30 PM
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Press...
GlobeNewswire
2:30 PM
Nano Dimension Is Partnering with Esko and Fiery to Provide an End-To-End Industry 4.0 Solution
GlobeNewswire
2:30 PM
SRIVARU (SVMH) Announces the Completion of State-of-the-Art Factory and Fully Automated EV Motorcycl...
GlobeNewswire
2:30 PM
GunBroker Partners with Gearfire Capital to Offer Innovative Financing Solutions for Firearms Retail...
GlobeNewswire
2:30 PM
Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Dist...
GlobeNewswire
2:30 PM
NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Va...
GlobeNewswire
2:30 PM
Golden Triangle Ventures, Inc. Announces Strategic Agreement with T&K Zarro, LLC to Strengthen Capit...
GlobeNewswire
2:30 PM
Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events
GlobeNewswire
2:30 PM
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depre...